Atlas Trials

Phase IV O2 Consumption Study in COPD Patients.

Clinical trial NCT02533505 · COMPLETED

Trial details

NCT number
NCT02533505
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary Disease (COPD)
Start date
2015-08-25
Primary completion
2016-08-12
Enrollment
51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.